A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/567 (2006.01) A61K 9/70 (2006.01) A61M 37/00 (2006.01) A61P 15/18 (2006.01)
Patent
CA 2624810
Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.
La présente invention concerne des formules et méthodes pour fournir une contraception à la progestine uniquement tout en minimisant plusieurs effets secondaires indésirables, tels qu~un saignement profus, qui sont normalement associés à une contraception à la progestine uniquement. Selon un aspect, la méthode peut inclure l~administration transdermale à la femme d~une formule ayant une quantité contraceptivement efficace d'une progestine unique comme seul agent hormonal actif, dans le cadre d'un régime contraceptif.
Anigbogu Angela
Ebert Charles
Hoel Gary
Roy Samir
Ridout & Maybee Llp
Watson Laboratories Inc.
LandOfFree
Formulations and methods for providing progestin-only... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations and methods for providing progestin-only..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations and methods for providing progestin-only... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2085813